Research & Development
CellGenix continuously expands its comprehensive portfolio of serum-free media, cytokines and other cell culture supplements according to the needs of the growing cell therapy field. We offer a diverse set of high-quality products for various cell types developed for different indications and therapeutic approaches.
The development of the manufacturing process takes into consideration our stringent animal-derived component free (ADCF) policy to ensure maximum safety of the product. Early involvement of skilled cell culture specialists guarantees the high-performance of our reagents.
In cooperation with leading international experts a current focus of our R&D activities lies on the development of innovative strategies for the generation of human hepatocytes from pluripotent stem cells and on the improvement of ex vivo expansion protocols for human hematopoietic stem cells.
A list of product references is available as download.